Dimensional Fund Advisors LP lifted its holdings in shares of The Clorox Company (NYSE:CLX – Free Report) by 0.9% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 928,632 shares of the company’s stock after purchasing an additional 8,087 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Clorox were worth $96,224,000 as of its most recent SEC filing.
Other institutional investors have also recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Clorox by 4.0% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock valued at $1,970,000 after acquiring an additional 514 shares during the last quarter. Woodline Partners LP grew its holdings in Clorox by 253.7% in the first quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock valued at $1,532,000 after purchasing an additional 7,465 shares during the period. Baird Financial Group Inc. raised its stake in Clorox by 1.7% during the second quarter. Baird Financial Group Inc. now owns 25,032 shares of the company’s stock worth $3,006,000 after purchasing an additional 424 shares during the period. Jump Financial LLC boosted its holdings in shares of Clorox by 173.5% in the 2nd quarter. Jump Financial LLC now owns 12,491 shares of the company’s stock valued at $1,500,000 after purchasing an additional 7,924 shares during the last quarter. Finally, Bank of Nova Scotia grew its stake in shares of Clorox by 26.2% during the 2nd quarter. Bank of Nova Scotia now owns 16,141 shares of the company’s stock valued at $1,938,000 after buying an additional 3,352 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
CLX has been the topic of a number of research analyst reports. Royal Bank Of Canada reduced their target price on Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a report on Thursday, April 9th. Barclays boosted their target price on Clorox from $85.00 to $86.00 and gave the stock an “underweight” rating in a report on Tuesday, July 21st. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $94.00 price target on shares of Clorox in a research report on Wednesday, July 22nd. JPMorgan Chase & Co. cut their target price on shares of Clorox from $95.00 to $92.00 and set an “underweight” rating on the stock in a research note on Thursday, July 16th. Finally, Zacks Research cut shares of Clorox from a “hold” rating to a “strong sell” rating in a research report on Tuesday, May 12th. Twelve research analysts have rated the stock with a Hold rating and five have given a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Reduce” and a consensus target price of $101.00.
Clorox Price Performance
CLX opened at $99.67 on Thursday. The Clorox Company has a twelve month low of $84.70 and a twelve month high of $128.90. The firm has a market cap of $12.05 billion, a price-to-earnings ratio of 16.18 and a beta of 0.54. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03. The company has a fifty day simple moving average of $95.46 and a 200 day simple moving average of $103.79.
Clorox (NYSE:CLX – Get Free Report) last issued its quarterly earnings data on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. The firm had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm’s revenue was up .1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.45 EPS. Equities research analysts expect that The Clorox Company will post 5.52 EPS for the current fiscal year.
Insider Activity at Clorox
In other Clorox news, Director Pierre R. Breber purchased 5,000 shares of Clorox stock in a transaction that occurred on Tuesday, May 5th. The stock was purchased at an average price of $85.82 per share, with a total value of $429,100.00. Following the completion of the acquisition, the director owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This trade represents a 38.46% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.63% of the company’s stock.
Clorox Profile
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
Featured Stories
- Five stocks we like better than Clorox
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
